The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Mar. 30, 2021

Filed:

Aug. 15, 2017
Applicant:

Universitetet I Oslo, Oslo, NO;

Inventors:
Assignee:
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07D 401/14 (2006.01); A61P 31/04 (2006.01); C07H 15/26 (2006.01); C07H 19/056 (2006.01); A61K 31/44 (2006.01); A61K 31/4436 (2006.01); A61K 47/54 (2017.01); A61K 31/69 (2006.01); A61K 31/496 (2006.01); A61K 31/706 (2006.01); A61K 31/5377 (2006.01); A61K 47/61 (2017.01); A61K 31/407 (2006.01); A61K 31/444 (2006.01); A61K 45/06 (2006.01);
U.S. Cl.
CPC ...
C07D 401/14 (2013.01); A61K 31/407 (2013.01); A61K 31/44 (2013.01); A61K 31/444 (2013.01); A61K 31/4436 (2013.01); A61K 31/496 (2013.01); A61K 31/5377 (2013.01); A61K 31/69 (2013.01); A61K 31/706 (2013.01); A61K 47/54 (2017.08); A61K 47/549 (2017.08); A61K 47/61 (2017.08); A61P 31/04 (2018.01); C07H 15/26 (2013.01); C07H 19/056 (2013.01); A61K 45/06 (2013.01);
Abstract

The invention provides compounds for use in a method of treating and/or preventing a bacterial infection in a human or non-human mammal, said method comprising administration of said compound in combination with (either simultaneously, separately, or sequentially) a β-lactam antibiotic, wherein said compound has the general formula I: (I) (wherein: Q is a lipophilic, zinc chelating moiety which is selective for Znions and which comprises at least one, preferably two or more (e.g 2, 3 or 4), optionally substituted, unsaturated heterocyclic rings, e.g. 5 or 6-membered heterocyclic rings (such rings preferably include at least one heteroatom selected from N, S and O, preferably N); wherein any optional substituents may be selected from Calkyl, Calkoxy, halogen, nitro, cyano, amine, and substituted amine; each L, which may be the same or different, is a covalent bond or a linker; each W, which may be the same or different, is a non-peptidic hydrophilic group which comprises one or more hydroxy groups; and x is an integer from 1 to 3) or a stereoisomer, pharmaceutically acceptable salt or prodrug thereof.


Find Patent Forward Citations

Loading…